Diagnosing and Managing Severe Hypertriglyceridemia in Familial Chylomicronemia Syndrome
CME
0.50
|
MOC
0.50
|
Nursing
0.50
Diagnosing and Managing Severe Hypertriglyceridemia in Familial Chylomicronemia Syndrome

This complimentary live program is designed to explore current issues with the underdiagnosis and misclassification of Familial Chylomicronemia Syndrome, identifying what distinguishes it from more common forms of hypertriglyceridemia, addressing the risk of pancreatitis, and examining evolving treatment methods, including new RNA-based treatments. 

  • Live Webinar Date: Friday, November 6, 2026
  • Time: 1:00-2:00 PM EST
Register
0.50
CME

 

Starts

11/6/2026

Expires

11/6/2027

Learning Objectives

Upon completion of the program, participants will be able to: 

  • Differentiate familial chylomicronemia syndrome (FCS) from other causes of severe hypertriglyceridemia by recognizing key clinical features, diagnostic criteria, and genetic considerations associated with delayed or missed diagnosis. 
  • Evaluate the impact of recurrent hypertriglyceridemia and acute pancreatitis in patients with FCS and apply evidence-based strategies to reduce pancreatitis risk, improve quality of life, and support long-term disease management. 
  • Integrate emerging and evolving therapies for FCS into individualized patient care plans through case-based application of treatment selection, multidisciplinary coordination, patient education, and practical implementation strategies in the endocrinology practice setting. 
Target Audience

The primary target audience for this program is endocrinologists and the endocrine care team, including nurses, nurse practitioners (NPs), physician assistants (PAs), and diabetologists.

View All Rare Endocrine Disease Webinars
Speakers/Faculty

Vishnu Priya Pulipati, MD, FACE, DiplABCL
Endocrinologist & Clinical Lipidologist
Warren Clinic, Saint Francis Health System
Tulsa, OK

Commercial Support

This activity is supported by an educational grant from Arrowhead Pharmaceuticals.